We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amdocs Limited (DOX - Free Report) reported first-quarter fiscal 2025 non-GAAP earnings of $1.66 per share, which came above the midpoint of management’s guidance range of $1.61-$1.67 and increased 6.4% year over year. The figure also exceeded the Zacks Consensus Estimate of $1.64.
In the trailing four quarters, DOX’s earnings surpassed the Zacks Consensus Estimate twice, matched once and missed once, with an average negative surprise of 0.1%.
Amdocs’ first-quarter revenues of $1.11 billion matched the consensus mark. However, compared with the year-ago quarter, revenues were down 10.9% on a reported basis due to the phase-out of certain business activities. Excluding the effect of phase-out business activities, revenues were up 1.7% year-over-year in pro forma constant currency.
Amdocs reported a decline in revenues across all regions due to the phase-out of certain business activities. North America reported revenues of $737.4 million (66.4% of total revenues), which plunged 12% year over year.
Europe revenues (14% of total revenues) of $155.2 decreased 14.4% year over year. Rest of the World (RoW) revenues (19.6% of total revenues) declined 3.7% year over year to $217.4 million. Our model estimates for North America, Europe and RoW were pinned at $733.2 million, $164 million and $215.8 million, respectively.
Managed services revenues rose 0.9% year over year to $729 million. The company ended the first quarter of fiscal 2025 with a 12-month backlog of $4.14 billion, up $80 million sequentially. Our model estimates for managed services revenues and backlog were pegged at $646 million and $3.73 billion, respectively.
The non-GAAP operating income increased 4.5% year over year to $235.4 million, while the operating margin expanded 310 basis points (bps) to 21.2%.
Amdocs’ Balance Sheet & Cash Flow
Amdocs had cash and short-term investments of $349 million as of Dec. 31, 2024, compared with $514.3 million as of Sept. 30, 2024. Long-term debt was $646.4 million as of Dec. 31, slightly higher than $646.3 million as of Sept. 30.
During the first quarter, it generated an operating cash flow of $105.6 million and a free cash flow of $78 million.
Amdocs Guidance Update
Amdocs initiated guidance for the second quarter and updated the outlook for the full fiscal 2025. For the second quarter, the company expects revenues to be in the band of $1.105-$1.145 billion (mid-point $1.125 billion). The Zacks Consensus Estimate for revenues is pegged at $1.12 billion, suggesting a year-over-year decline of 9.7%.
Amdocs expects non-GAAP earnings per share to be between $1.67 and $1.73. The Zacks Consensus Estimate for earnings is pegged at $1.69 per share, indicating a year-over-year rise of 8.3%.
For fiscal 2025, Amdocs now expects revenues to decline between 8.4% and 11.6% on a year-over-year basis, slightly higher than the previous guidance of a decline of 7.7-10.9%. The Zacks Consensus Estimate for revenues is pegged at $4.52 billion, suggesting a year-over-year decline of 9.6%.
Non-GAAP operating margin is still anticipated to be in the range of 21.1-21.7% for fiscal 2025. Non-GAAP earnings are still expected to grow in the band of 6.5-10.5%. The Zacks Consensus Estimate for earnings is pegged at $6.97 per share, indicating a year-over-year rise of 8.2%.
The company continues to expect free cash flow between $710 million and $730 million.
Gitlab shares have dropped 4% for the past year. The Zacks Consensus Estimate for GTLB’s full-year 2025 earnings is pegged at 63 cents per share, indicating a 210% year-over-year increase.
Planet Labs PBC shares have surged 152% in the past year. The Zacks Consensus Estimate for PL’s fiscal 2025 bottom line is pinned at a loss of 15 cents per share. In the year-ago quarter, the company had reported a loss of 50 cents per share.
Fortinet shares have gained 52.2% for the past year. The Zacks Consensus Estimate for FTNT’s full-year 2025 earnings is pegged at $2.39 per share, suggesting an increase of 6.5% from the year-ago quarter’s reported figure.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Amdocs Beats on Q1 Earnings and Revenue Estimates
Amdocs Limited (DOX - Free Report) reported first-quarter fiscal 2025 non-GAAP earnings of $1.66 per share, which came above the midpoint of management’s guidance range of $1.61-$1.67 and increased 6.4% year over year. The figure also exceeded the Zacks Consensus Estimate of $1.64.
In the trailing four quarters, DOX’s earnings surpassed the Zacks Consensus Estimate twice, matched once and missed once, with an average negative surprise of 0.1%.
Amdocs’ first-quarter revenues of $1.11 billion matched the consensus mark. However, compared with the year-ago quarter, revenues were down 10.9% on a reported basis due to the phase-out of certain business activities. Excluding the effect of phase-out business activities, revenues were up 1.7% year-over-year in pro forma constant currency.
Amdocs Limited Price, Consensus and EPS Surprise
Amdocs Limited price-consensus-eps-surprise-chart | Amdocs Limited Quote
Amdocs’ Q1 Details
Amdocs reported a decline in revenues across all regions due to the phase-out of certain business activities. North America reported revenues of $737.4 million (66.4% of total revenues), which plunged 12% year over year.
Europe revenues (14% of total revenues) of $155.2 decreased 14.4% year over year. Rest of the World (RoW) revenues (19.6% of total revenues) declined 3.7% year over year to $217.4 million. Our model estimates for North America, Europe and RoW were pinned at $733.2 million, $164 million and $215.8 million, respectively.
Managed services revenues rose 0.9% year over year to $729 million. The company ended the first quarter of fiscal 2025 with a 12-month backlog of $4.14 billion, up $80 million sequentially. Our model estimates for managed services revenues and backlog were pegged at $646 million and $3.73 billion, respectively.
The non-GAAP operating income increased 4.5% year over year to $235.4 million, while the operating margin expanded 310 basis points (bps) to 21.2%.
Amdocs’ Balance Sheet & Cash Flow
Amdocs had cash and short-term investments of $349 million as of Dec. 31, 2024, compared with $514.3 million as of Sept. 30, 2024. Long-term debt was $646.4 million as of Dec. 31, slightly higher than $646.3 million as of Sept. 30.
During the first quarter, it generated an operating cash flow of $105.6 million and a free cash flow of $78 million.
Amdocs Guidance Update
Amdocs initiated guidance for the second quarter and updated the outlook for the full fiscal 2025. For the second quarter, the company expects revenues to be in the band of $1.105-$1.145 billion (mid-point $1.125 billion). The Zacks Consensus Estimate for revenues is pegged at $1.12 billion, suggesting a year-over-year decline of 9.7%.
Amdocs expects non-GAAP earnings per share to be between $1.67 and $1.73. The Zacks Consensus Estimate for earnings is pegged at $1.69 per share, indicating a year-over-year rise of 8.3%.
For fiscal 2025, Amdocs now expects revenues to decline between 8.4% and 11.6% on a year-over-year basis, slightly higher than the previous guidance of a decline of 7.7-10.9%. The Zacks Consensus Estimate for revenues is pegged at $4.52 billion, suggesting a year-over-year decline of 9.6%.
Non-GAAP operating margin is still anticipated to be in the range of 21.1-21.7% for fiscal 2025. Non-GAAP earnings are still expected to grow in the band of 6.5-10.5%. The Zacks Consensus Estimate for earnings is pegged at $6.97 per share, indicating a year-over-year rise of 8.2%.
The company continues to expect free cash flow between $710 million and $730 million.
DOX’s Zacks Rank & Stocks to Consider
Currently, Amdocs carries a Zacks Rank #3 (Hold).
Gitlab (GTLB - Free Report) , Planet Labs PBC (PL - Free Report) and Fortinet (FTNT - Free Report) are some top-ranked stocks that investors can consider in the broader Zacks Computer and Technology sector. GTLB, PL and FTNT carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Gitlab shares have dropped 4% for the past year. The Zacks Consensus Estimate for GTLB’s full-year 2025 earnings is pegged at 63 cents per share, indicating a 210% year-over-year increase.
Planet Labs PBC shares have surged 152% in the past year. The Zacks Consensus Estimate for PL’s fiscal 2025 bottom line is pinned at a loss of 15 cents per share. In the year-ago quarter, the company had reported a loss of 50 cents per share.
Fortinet shares have gained 52.2% for the past year. The Zacks Consensus Estimate for FTNT’s full-year 2025 earnings is pegged at $2.39 per share, suggesting an increase of 6.5% from the year-ago quarter’s reported figure.